APO-RABEPRAZOLE rabeprazole sodium 20mg enteric coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-rabeprazole rabeprazole sodium 20mg enteric coated tablet blister pack

arrotex pharmaceuticals pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: ethylcellulose; iron oxide yellow; sodium starch glycollate type a; light magnesium oxide; diethyl phthalate; magnesium stearate; titanium dioxide; hypromellose phthalate; mannitol; povidone; purified talc - rabeprazole is indicated for: - treatment and prevention of relapse of gastro-oesophageal reflux disease. - symptomatic treatment of gastro-oesophageal reflux disease. - treatment of duodenal ulcers. - treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: - eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis. - healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

APO-RABEPRAZOLE rabeprazole sodium 10mg enteric coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-rabeprazole rabeprazole sodium 10mg enteric coated tablet blister pack

arrotex pharmaceuticals pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: povidone; mannitol; sodium starch glycollate type a; diethyl phthalate; purified talc; magnesium stearate; hypromellose phthalate; light magnesium oxide; iron oxide red; titanium dioxide; ethylcellulose - rabeprazole is indicated for: - treatment and prevention of relapse of gastro-oesophageal reflux disease. - symptomatic treatment of gastro-oesophageal reflux disease. - treatment of duodenal ulcers. - treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: - eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis. - healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

RABEPRAZOLE ALPHAPHARM rabeprazole sodium 10 mg enteric-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

rabeprazole alphapharm rabeprazole sodium 10 mg enteric-coated tablet blister pack

bafna pharmaceuticals pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: titanium dioxide; hypromellose phthalate; acetylated monoglycerides; heavy magnesium oxide; iron oxide red; hyprolose; mannitol; ethylcellulose; magnesium stearate; purified talc; hypromellose; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - rabeprazole alphapharm is indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,rabeprazole alphapharm is also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

RABEPRAZOLE ALPHAPHARM rabeprazole sodium 20 mg enteric-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

rabeprazole alphapharm rabeprazole sodium 20 mg enteric-coated tablet blister pack

bafna pharmaceuticals pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: purified talc; titanium dioxide; hyprolose; heavy magnesium oxide; acetylated monoglycerides; ethylcellulose; magnesium stearate; mannitol; hypromellose phthalate; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; hypromellose - rabeprazole alphapharm is indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,rabeprazole alphapharm is also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

PARZOL 20 rabeprazole sodium 20 mg enteric coated tablets blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

parzol 20 rabeprazole sodium 20 mg enteric coated tablets blister pack

medis pharma pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: methacrylic acid - ethyl acrylate copolymer (1:1); mannitol; sodium lauryl sulfate; ethylcellulose; polysorbate 80; magnesium stearate; hyprolose; purified talc; iron oxide yellow; povidone; light magnesium oxide; propylene glycol; titanium dioxide - rabeprazole is indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

ZABEP 20 rabeprazole sodium 20 mg enteric coated tablets blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

zabep 20 rabeprazole sodium 20 mg enteric coated tablets blister pack

medis pharma pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: iron oxide yellow; propylene glycol; povidone; sodium lauryl sulfate; magnesium stearate; titanium dioxide; methacrylic acid - ethyl acrylate copolymer (1:1); mannitol; light magnesium oxide; purified talc; hyprolose; polysorbate 80; ethylcellulose - rabeprazole is indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Parbezol rabeprazole sodium 20mg enteric coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

parbezol rabeprazole sodium 20mg enteric coated tablet blister pack

arrotex pharmaceuticals pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: ethylcellulose; iron oxide yellow; mannitol; diethyl phthalate; hypromellose phthalate; sodium starch glycollate type a; light magnesium oxide; magnesium stearate; titanium dioxide; purified talc; povidone - rabeprazole is indicated for: - treatment and prevention of relapse of gastro-oesophageal reflux disease. - symptomatic treatment of gastro-oesophageal reflux disease. - treatment of duodenal ulcers. - treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: - eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis. - healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Parbezol rabeprazole sodium 10mg enteric coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

parbezol rabeprazole sodium 10mg enteric coated tablet blister pack

arrotex pharmaceuticals pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: sodium starch glycollate type a; diethyl phthalate; purified talc; povidone; titanium dioxide; iron oxide red; hypromellose phthalate; ethylcellulose; magnesium stearate; light magnesium oxide; mannitol - rabeprazole is indicated for: - treatment and prevention of relapse of gastro-oesophageal reflux disease. - symptomatic treatment of gastro-oesophageal reflux disease. - treatment of duodenal ulcers. - treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: - eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis. - healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

RABEPRAZOLE RAN rabeprazole sodium 20 mg enteric coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

rabeprazole ran rabeprazole sodium 20 mg enteric coated tablet blister pack

sun pharma anz pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: hypromellose phthalate; diacetylated monoglycerides; ethylcellulose; iron oxide yellow; heavy magnesium oxide; magnesium stearate; hyprolose; light magnesium oxide; titanium dioxide; purified talc; mannitol; propylene glycol; butan-1-ol; allura red ac aluminium lake; industrial methylated spirit; ethanol; shellac; strong ammonia solution; sulfuric acid - treatment and prevention of relapse of gastro-oesophageal reflux disease. symptomatic treatment of gastro-oesophageal reflux disease. treatment of duodenal ulcers. treatment of gastric ulcers.,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,also indicated, in combination with clarithromycin and amoxycillin, for: - eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis - healing of peptic ulcers in patients with helicobacter pylori associated ulcers.